GIGAGEN Trademark

Trademark Overview


On Wednesday, April 8, 2020, a trademark application was filed for GIGAGEN with the United States Patent and Trademark Office. The USPTO has given the GIGAGEN trademark a serial number of 88864823. The federal status of this trademark filing is REGISTERED as of Tuesday, May 4, 2021. This trademark is owned by GigaGen, Inc.. The GIGAGEN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical and therapeutic preparations for the treatment of immune deficiencies, autoimmune diseases, oncological diseases and disorders, infectious diseases, and organ, tissue, or cell transplant tolerance; therapeutic antibodies for the treatment of immune deficiencies, autoimmune diseases, oncological diseases and disorders, infectious diseases, and organ, tissue, or cell transplant tolerance

pharmaceutical drug discovery; research and development in the field of antibody-based therapies; research and development of pharmaceuticals in the fields of oncology, immunology, infectious diseases, and organ, tissue, or cell transplant tolerance; Scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics; scientific research in the nature of machine learning on single-cell data to identify and quantify cell type differences for the purpose of discovering novel targets; Medical and scientific research for the identification, preparation, and development of antibody libraries; DNA, protein, and antibody screening for scientific research purposes
gigagen

General Information


Serial Number88864823
Word MarkGIGAGEN
Filing DateWednesday, April 8, 2020
Status700 - REGISTERED
Status DateTuesday, May 4, 2021
Registration Number6343231
Registration DateTuesday, May 4, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 23, 2020

Trademark Statements


Goods and Servicespharmaceutical and therapeutic preparations for the treatment of immune deficiencies, autoimmune diseases, oncological diseases and disorders, infectious diseases, and organ, tissue, or cell transplant tolerance; therapeutic antibodies for the treatment of immune deficiencies, autoimmune diseases, oncological diseases and disorders, infectious diseases, and organ, tissue, or cell transplant tolerance
Goods and Servicespharmaceutical drug discovery; research and development in the field of antibody-based therapies; research and development of pharmaceuticals in the fields of oncology, immunology, infectious diseases, and organ, tissue, or cell transplant tolerance; Scientific research, namely, research and analysis services in the fields of artificial intelligence and machine learning analytics; scientific research in the nature of machine learning on single-cell data to identify and quantify cell type differences for the purpose of discovering novel targets; Medical and scientific research for the identification, preparation, and development of antibody libraries; DNA, protein, and antibody screening for scientific research purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 16, 2020
Primary Code005
First Use Anywhere DateFriday, February 28, 2014
First Use In Commerce DateWednesday, January 20, 2021

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 16, 2020
Primary Code042
First Use Anywhere DateSunday, February 28, 2010
First Use In Commerce DateFriday, February 28, 2014

Trademark Owner History


Party NameGigaGen, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameGigaGen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameGigaGen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Tuesday, May 4, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, March 30, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, March 29, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 4, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 10, 2021USE AMENDMENT FILED
Tuesday, March 2, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 10, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, August 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 23, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 23, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 3, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 18, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 12, 2020ASSIGNED TO EXAMINER
Thursday, April 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 11, 2020NEW APPLICATION ENTERED IN TRAM